Does perioperative high-dose prednisolone have clinical benefits for generalized myasthenia gravis?

European Journal of Cardio-thoracic Surgery

Volumn 29, Issue 6, 2006, Pages 908-913

  Sekine, Yasuo ^a   Kawaguchi, Naoki ^a   Hamada, Chikuma ^b   Sekiguchi, Hiromi ^b   Yasufuku, Kazuhiro ^a   Iyoda, Akira ^a   Shibuya, Kiyoshi ^a   Fujisawa, Takehiko ^a  

^a CHIBA UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Extended thymectomy; High dose prednisolone; Long term outcome; Myasthenia gravis

Indexed keywords

PREDNISOLONE; PYRIDOSTIGMINE; STEROID;

ADULT; ARTICLE; BLEEDING; CATARACT; COMPRESSION FRACTURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE EXACERBATION; DRUG DOSE REGIMEN; DRUG MEGADOSE; FEMALE; HUMAN; LIFE TABLE; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; MYASTHENIC CRISIS; OSTEOPOROSIS; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; REMISSION; RETROSPECTIVE STUDY; THYMECTOMY; THYMOMA; VERTEBRA FRACTURE;

ADULT; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION; EPIDEMIOLOGIC METHODS; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; PREDNISOLONE; RECURRENCE; SEVERITY OF ILLNESS INDEX; THYMECTOMY; TREATMENT OUTCOME;

EID: 33646589047     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2006.03.022     Document Type: Article

References (23)

1. Engel A.G., Lambert E.H., and Santa T. Study of long-term anticholinesterase therapy: effects on neuromuscular transmission and on motor endplate fine structure. Neurology 23 (1973) 1273-1281
2. Arsura E.L., Brunner N.G., Mamba T., and Grob D. Adverse cardiovascular effects of anticholinesterase medications. Am J Med Sci 293 (1987) 18-23
3. Yamaguchi Y., Saito Y., Baba M., and Obata S. Favorable results of thymectomy combined with prednisolone alternate-day administration in myasthenia gravis. Jpn J Surg 17 (1987) 14-20
4. Jaretzki III A., Barohn R.J., Ernstoff R.M., Kaminski H.J., Keesey J.C., Penn A.S., and Sanders D.B. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Ann Thorac Surg 70 (2000) 327-334
5. Seybold M.E., and Drachman D.B. Gradually increasing doses of prednisolone in myasthenia gravis. Reducing the hazards of treatment. N Engl J Med 290 (1974) 81-84
6. Masaoka A., Yamakawa Y., Niwa H., Fukai I., Kondo S., Kobayashi M., Fujii Y., and Monden Y. Extended thymectomy for myasthenia gravis patients: a 20-year review. Ann Thorac Surg 62 (1996) 853-859
7. Watanabe A., Watanabe T., Obama T., Mawatari T., Ohsawa H., Ichimiya Y., Takahashi N., Kusajima K., and Abe T. Prognostic factors for myasthenic crisis after transsternal thymectomy in patients with myasthenia gravis. J Thorac Cardiovasc Surg 127 (2004) 868-876
8. Shrager J.B., Deeb M.E., Mick R., Brinster C.J., Childers H.E., Marshall M.B., Kucharczuk J.C., Galetta S.L., Bird S.J., and Kaiser L.R. Transcervical thymectomy for myasthenia gravis achieves results comparable to thymectomy by sternotomy. Ann Thorac Surg 74 (2002) 320-326
9. Jaretzki A. Thymectomy for myasthenia gravis: analysis of the controversies regarding technique and results. Neurology 48 (1997) S52-S63
10. de Perrot M., Bril V., McRae K., and Keshavjee S. Impact of minimally invasive trans-cervical thymectomy on outcome in patients with myasthenia gravis. Eur J Cardiothorac Surg 24 (2003) 677-683
11. Olanow C.W., Wechsler A.S., Sirotkin-Roses M., Stajich J., and Roses A.D. Thymectomy as primary therapy in myasthenia gravis. Ann NY Acad Sci 505 (1987) 595-606
12. Bedlack R.S., and Sanders D.B. Steroid treatment for myasthenia gravis: steroids have an important role. Muscle Nerve 25 (2002) 117-121
13. Rivner M.H. Steroid treatment for myasthenia gravis: steroids are overutilized. Muscle Nerve 25 (2002) 115-117
14. Wakata N., Nemoto H., Sugimoto H., Nomoto N., Konno S., Hayashi N., Araki Y., and Nakazato A. Bone density in myasthenia gravis patients receiving long-term prednisolone therapy. Clin Neurol Neurosurg 106 (2004) 139-141
15. Kas J., Kiss D., Simon V., Svastics E., Major L., and Szobor A. Decade-long experience with surgical therapy of myasthenia gravis: early complications of 324 transsternal thymectomies. Ann Thorac Surg 72 (2001) 1691-1697
16. Pego-Fernandes P.M., de Campos J.R., Jatene F.B., Marchiori P., Suso F.V., and de Oliveira S.A. Thymectomy by partial sternotomy for the treatment of myasthenia gravis. Ann Thorac Surg 74 (2002) 204-208
17. Olanow C.W., Wechsler A.S., and Roses A.D. A prospective study of thymectomy and serum acetylcholine receptor antibodies in myasthenia gravis. Ann Surg 196 (1982) 113-121
18. Remes-Troche J.M., Tellez-Zenteno J.F., Estanol B., Garduno-Espinoza J.G., and Gracia-Ramos G. Thymectomy in myasthenia gravis: response, complications, and associated conditions. Arch Med Res 33 (2002) 545-551
19. Ozdemir N., Kara M., Dikmen E., Nadir A., Akal M., Yucemen N., and Yavuzer S. Predictors of clinical outcome following extended thymectomy in myasthenia gravis. Eur J Cardiothorac Surg 23 (2003) 233-237
20. Wakata N., Iguchi H., Sugimoto H., Nomoto N., and Kurihara T. Relapse of ocular symptoms after remission of myasthenia gravis-a comparison of relapsed and complete remission cases. Clin Neurol Neurosurg 105 (2003) 75-77
21. Scherpbier H.J., and Oosterhuis H.J. Factors influencing the relapse risk at steroid dose reduction in myasthenia gravis. Clin Neurol Neurosurg 89 (1987) 145-150
22. Beghi E., Antozzi C., Batocchi A.P., Cornelio F., Cosi V., Evoli A., Lombardi M., Mantegazza R., Monticelli M.L., and Piccolo G. Prognosis of myasthenia gravis: a multicenter follow-up study of 844 patients. J Neurol Sci 106 (1991) 213-220
23. Lovelace R.E., and Younger D.S. Myasthenia gravis with thymoma. Neurology 48 Suppl 5 (1997) S76-S81